For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
LPI (LP Information)' newest research report, the "Methotrexate Industry Forecast" looks at past sales and reviews total world Methotrexate sales in 2022, providing a comprehensive analysis by region and market sector of projected Methotrexate sales for 2023 through 2029. With Methotrexate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Methotrexate industry.
This Insight Report provides a comprehensive analysis of the global Methotrexate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Methotrexate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Methotrexate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Methotrexate and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Methotrexate.
The global Methotrexate market size is projected to grow from US$ 506 million in 2022 to US$ 613.9 million in 2029; it is expected to grow at a CAGR of 613.9 from 2023 to 2029.
North America is the largest Methotrexate market with about 49% market share. China is follower, accounting for about 12% market share.
The key players are Teva Pharmaceutical Industries, Qualitestrx(DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone, Huiyu etc. Top 3 companies occupied about 65% market share.
This report presents a comprehensive overview, market shares, and growth opportunities of Methotrexate market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Methotrexate for Injection
- Methotrexate Tablets
Segmentation by application
- Used for Cancers
- Used for Rheumatoid Arthritis
- Used for Other Diseases
The below companies that are profiled
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Teva Pharmaceutical Industries
- Qualitestrx (DAVA Pharmaceuticals)
- Pfizer (Hospira)
- Roxane Laboratories
- Sine
- Maoxiang
- LingNan Pharmaceutical
- Powerdone
- Huiyu
Key Questions Addressed in this Report
What is the 10-year outlook for the global Methotrexate market?
What factors are driving Methotrexate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Methotrexate market opportunities vary by end market size?
How does Methotrexate break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?